Prime Medicine, Inc. (PRME)
3.255
-0.14
(-3.98%)
USD |
NASDAQ |
Aug 24, 16:00
3.26
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Total Liabilities (Quarterly) : 209.23M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 209.23M |
| March 31, 2026 | 218.03M |
| December 31, 2025 | 495.77M |
| September 30, 2025 | 223.19M |
| June 30, 2025 | 218.15M |
| March 31, 2025 | 221.24M |
| December 31, 2024 | 336.99M |
| September 30, 2024 | 143.28M |
| June 30, 2024 | 63.12M |
| March 31, 2024 | 67.62M |
| December 31, 2023 | 183.82M |
| September 30, 2023 | 45.19M |
| Date | Value |
|---|---|
| June 30, 2023 | 40.76M |
| March 31, 2023 | 38.14M |
| December 31, 2022 | 114.64M |
| September 30, 2022 | 42.56M |
| June 30, 2022 | 46.86M |
| March 31, 2022 | 15.69M |
| December 31, 2021 | 62.30M |
| September 30, 2021 | 13.81M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 21.31M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 318.91M |
| Twist Bioscience Corp. | 226.70M |
| Sana Biotechnology, Inc. | 276.95M |
| Generate Biomedicines, Inc. | 105.64M |
| Intellia Therapeutics, Inc. | 129.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 249.04M |
| Shareholders Equity (Quarterly) | 39.81M |
| Debt to Equity Ratio | 2.825 |
| Current Ratio | 3.054 |
| Net Debt Paydown Yield | 0.26% |